|
2026
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disea... |
|
2025
|
Invention
|
Methods for enhanced removal of impurities during protein a chromatography.
Provided herein are ... |
|
|
Invention
|
Mobile electronic device for illuminating veins. In one aspect the present disclosure relates to ... |
|
|
Invention
|
Lipid nanoparticles targeting central nervous system endothelial cells. Provided are lipid nanopa... |
|
|
Invention
|
Modified mammalian cells for improved production. Provided herein are engineered or modified cell... |
|
|
Invention
|
Process for inserting targeting ligand into a lipid nanoparticle encapsulating nucleic acid and c... |
|
|
Invention
|
Methods and compositions for raav production. The present disclosure provides methods of producin... |
|
|
Invention
|
Process for preparing (s)-5-benzyl-n-(5-methyl-4-oxo-2,3,4,5- tetrahydropyrido[3,2-b][l,4]oxazepi... |
|
|
Invention
|
Adapter and injection kit. In one aspect the present disclosure relates to an adapter for connect... |
|
|
G/S
|
Medical and scientific research, namely, conducting clinical trials for others; Providing medical... |
|
|
G/S
|
Medical and scientific research services, namely conducting clinical trials in the medical field. |
|
|
Invention
|
Rodent model for serpina1 gene correction. Provided herein are humanized rodent models comprising... |
|
|
Invention
|
Devices for cell lysis and methods of use thereof.
Provided herein are methods for isolating int... |
|
|
Invention
|
Inhibitors of glucosylceramide synthase.
The hemitartrate salt of a compound represented by the ... |
|
|
Invention
|
Ionizable cationic lipids and lipid nanoparticles, and methods of synthesis and use thereof. The ... |
|
|
Invention
|
Production of recombinant aav. The present disclosure provides methods of producing in a single c... |
|
|
Invention
|
Methods and compositions for treating hemophilia.
The present disclosure provides using a double... |
|
|
Invention
|
Aav-mediated ocular gene therapy. The present disclosure provides a method of reducing the levels... |
|
|
Invention
|
Macrocyclic compounds, compositions, and methods of using thereof.
The present disclosure includ... |
|
|
Invention
|
Macrocyclic compounds, compositions, and methods of using thereof. The present disclosure include... |
|
|
Invention
|
Methods and systems for processing a cell culture.
Provided herein are methods of processing a c... |
|
|
Invention
|
Anti-alphabetatcr antibody.
The present invention relates to humanized monoclonal antibodies com... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device has a needle for injecting medicament in... |
|
|
Invention
|
Preparation assembly and method of preparing a liquid medicament. A preparation assembly for prep... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device has a needle, a body and a needle cover ... |
|
|
Invention
|
A medicament delivery device. There is provided a medicament delivery device comprising: a main b... |
|
|
Invention
|
Methods and compositions for raav production. The disclosure relates, at least in part, to method... |
|
|
Invention
|
Enhanced delivery of viral particles to the striatum and cortex.
Provided herein are novel metho... |
|
|
Invention
|
Lipid nanoparticles and methods of manufacture and use thereof.
The present disclosure relates g... |
|
|
Invention
|
Lipid nanoparticles and methods of manufacture and use thereof. in vivoin vivo. |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of somatostatin-expressing neuroendo... |
|
|
Invention
|
Method for selectively controlling the generation of degradants from a biological product exposed... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device comprises: a needle for injecting a medi... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device comprises: a body; a needle cover axiall... |
|
|
Invention
|
Neural network system for endoscopic scoring of gastrointestinal disease. The specification descr... |
|
|
G/S
|
Chemicals, namely, hyaluronic acid, hyaluronans and hylan polymers, and derivatives thereof, for ... |
|
|
Invention
|
Perfusion in production bioreactors. The present disclosure provides methods of producing recombi... |
|
|
Invention
|
Eliglustat for the treatment of gaucher disease. Disclosed are methods of treating Gaucher diseas... |
|
|
Invention
|
Anti-alpha beta tcr binding polypeptides with reduced fragmentation.
The present disclosure is r... |
|
|
Invention
|
Medicament delivery device. The present disclosure relates to a medicament delivery device compri... |
|
|
Invention
|
Medicament delivery device. |
|
|
Invention
|
Medicament delivery device. A medicament delivery device has a needle for injecting medicament, a... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device comprises a housing, a needle, a needle ... |
|
|
G/S
|
Advertising services to promote awareness of patients regarding multiple sclerosis. Providing onl... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device for injecting medicament is described. T... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device comprising: a proximal end and a distal ... |
|
2024
|
Invention
|
Medicament delivery device. A medicament delivery device comprises a syringe body configured to r... |
|
|
G/S
|
Downloadable software in the nature of a mobile application for enabling users to enter, access, ... |
|
|
Invention
|
Medicament delivery device.
A medicament delivery device has a needle for injecting medicament i... |
|
|
Invention
|
Medicament delivery device. The present disclosure relates to a medicament delivery device. The m... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disea... |
|
|
G/S
|
Chemicals for use in the manufacture of cosmetic, personal
care and pharmaceutical products. |
|
2023
|
G/S
|
Pharmaceutical products for the prevention and treatment of immunological diseases; pharmaceutica... |
|
|
G/S
|
Pharmaceutical products for the prevention and treatment of immunological diseases, pharmaceutica... |
|
|
Invention
|
Methods of optimizing dissolved oxygen levels in cell culture.
Provided herein are methods of se... |
|
|
G/S
|
Pharmaceuticals for use in the treatment of lysosomal storage diseases |
|
|
G/S
|
Support services for patients and caregivers in the field of rare genetic diseases and disorders,... |
|
2017
|
Invention
|
Recombinant aav vectors expressing osteoprotective genes, including has2 and lubricin, useful in ... |
|
2016
|
Invention
|
Analytical ultracentrifugation for characterization of recombinant viral particles. Provided here... |
|
2015
|
Invention
|
Adeno-associated viral vectors for treating myocilin (myoc) glaucoma. Provided herein are methods... |
